Cynthia Kern, Director, Officer of Investigator-Sponsored IND and IDE Support Office
This presentation will include an overview and discussion of commonly used FDA forms in the submission of Investigational New Drug applications and subsequent FDA correspondence. Forms to be discussed will include 1571, 1572, 3500a, 3674 and 3926.
No registration required. Submit advance questions or comments to email@example.com.